CD71 in gestational pathology: A versatile immunohistochemical marker with new possible applications

Applied Immunohistochemistry and Molecular Morphology

Volumn 24, Issue 3, 2016, Pages 215-220

  Luchini, Claudio ^a,c   Parcesepe, Pietro ^a   Nottegar, Alessia ^a   Parolini, Claudia ^a   Mafficini, Andrea ^a   Remo, Andrea ^b   Chilosi, Marco ^a   Manfrin, Erminia ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Ospedale Mater Salutis   (Italy)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD71; molar pregnancy; nucleated red blood cells; transferrin receptor; trophoblast

Indexed keywords

BIOLOGICAL MARKER; CD71 ANTIGEN; LEUKOCYTE ANTIGEN; TRANSFERRIN RECEPTOR;

ANTIBODY LABELING; ARTICLE; CHORION VILLUS; CLINICAL ARTICLE; ECTOPIC PREGNANCY; ERYTHROCYTE; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; NECROSIS; NUCLEATED RED BLOOD CELL; PARTIAL MOLAR PREGNANCY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION;

ANTIGENS, CD; BIOMARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TRANSFERRIN;

EID: 84962598403     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0000000000000175     Document Type: Article

References (20)

1. Ponnusamy S, Zhang H, Kadam P, et al. Membrane proteins of human fetal primitive nucleated red blood cells. J Proteomics. 2012; 75:5762-5773.
2. Gilbert-Barness E, Kapur RP, Oligny LL, et al. Potters Pathology of the Fetus, Infant and Child. 2nd ed. Maryland Heights: Mosby Elsevier Inc.; 2007.
3. Mathew A, Bell A, Johnstone RM. Hsp-70 is closely associated with the transferrin receptor in exosomes from maturing reticulocytes. Biochem J. 1995;308:823-830.
4. Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor) an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol. 2010;134:429-435.
5. Habashy HO, Powe DG, Staka CM, et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat. 2010;119:283-293.
6. Chan KT, Choi MY, Lai KK, et al. Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma. Oncol Rep. 2014;31:1296-1304.
7. Malleret B, Xu F, Mohandas N, et al. Significant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytes. PLoS One. 2013;8:e76062.
8. Dong HY, Wilkes S, Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: A comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Pathol. 2011;35:723-732.
9. Bulmer JN, Thrower S, Wells M. Expression of epidermal growth factor receptor and transferrin receptor by human trophoblast populations. Am J Reprod Immunol. 1989;21:87-93.
10. Tsunoo H, Sussman HH. Characterization of transferrin binding and specificity of the placental transferrin receptor. Arch Biochem Biophys. 1983;225:42-54.
11. Berkowitz RS, Dubey DP, Goldstein DP, et al. Localization of transferrin receptor in the chorionic villi of complete molar pregnancy. Am J Obstet Gynecol. 1985;151:128-129.
12. Lawler SD, Fisher RA. Genetic studies in hydatidiform mole with clinical correlations. Placenta. 1987;8:77-88.
13. Buza N, Hui P. Immunohistochemistry and other techniques in the diagnosis of gestational trophoblastic disease. Semin Diagn Pathol. 2014;31:223-232.
14. Chen KH, Hsu SC, Chen HY, et al. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles. Biochem Biophys Res Commun. 2014;446:555-560.
15. Banet N, DeScipio C, Murphy KM, et al. Characteristics of hydatidiform moles: Analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014;27:238-254.
16. Sundvall L, Lund H, Niemann I, et al. Tetraploidy in hydatidiform moles. Hum Reprod. 2013;28:2010-2020.
17. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: Ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011; 30:101-116.
18. Sebire NJ, Seckl MJ. Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directions. J Reprod Med. 2010;55:236-246.
19. Khooei A, Atabaki Pasdar F, Fazel A, et al. Ki-67 expression in hydatidiform moles and hydropic abortions. Iran Red Crescent Med J. 2013;15:590-594.
20. Heidarpour M, Khanahmadi M. Diagnostic value of P63 in differentiating normal gestation from molar pregnancy. J Res Med Sci. 2013;18:462-466.